经皮室间隔化学消融术治疗肥厚性梗阻型心肌病的围术期护理
|
摘要
目的探讨经皮室间隔化学消融术治疗肥厚性梗阻型心肌病的围术期护理。方法回顾性分析55例肥厚性梗阻型心肌病行经皮室间隔化学消融术患者的病案资料,总结患者术前、术中、术后的护理。结果术中出现47例轻、中度胸痛,8例重度胸痛,1例迷走反射,55例右束支传导阻滞,4例左束支传导阻滞,36例Ⅲ度房室传导阻滞,55例多源性室早。术后55例患者均有不同程度的胸痛,3例Ⅲ度房室传导阻滞,48例室性早搏,治疗后均转为窦性心律,康复出院。结论加强围术期的观察可以提高护理质量,减少并发症的发生,提高手术效果,促进患者康复。
Objective The explore the perioperative nursing for patents with hypertrophic obstructive cardiomyopathy by treatment of percutaneous septal chemical ablation. Methods Clinical materials of 55 patients with hypertrophic obstructive cardiomyopathy by treatment of percutaneous septal chemical ablation were analyzed retrospectively,and the whole nursing measures were summarized. Results There were 47 cases of mild and moderate chest pain,8 cases of severe chest pain,1 case of vagal reflex,55 cases of right bundle branch block,4 cases of left bundle branch block,36 cases of degree Ⅲ atrioventricular block and 55 cases of polygenic ventricular premature. Fifty-five patients had chest pain with varying degrees,3 patients had degree Ⅲ atrioventricular block and 48 patients had ventricular premature beats. After treatment,all patients were converted to sinus rhythm and discharged from hospital. Conclusion Strengthening perioperative observation can improve the quality of nursing,reduce complications,improve the effect of operation and promote the rehabilitation of patients.
Objective The explore the perioperative nursing for patents with hypertrophic obstructive cardiomyopathy by treatment of percutaneous septal chemical ablation. Methods Clinical materials of 55 patients with hypertrophic obstructive cardiomyopathy by treatment of percutaneous septal chemical ablation were analyzed retrospectively,and the whole nursing measures were summarized. Results There were 47 cases of mild and moderate chest pain,8 cases of severe chest pain,1 case of vagal reflex,55 cases of right bundle branch block,4 cases of left bundle branch block,36 cases of degree Ⅲ atrioventricular block and 55 cases of polygenic ventricular premature. Fifty-five patients had chest pain with varying degrees,3 patients had degree Ⅲ atrioventricular block and 48 patients had ventricular premature beats. After treatment,all patients were converted to sinus rhythm and discharged from hospital. Conclusion Strengthening perioperative observation can improve the quality of nursing,reduce complications,improve the effect of operation and promote the rehabilitation of patients.
引文
[1] Richard P,Charron P,Carrier L,et al. Hypertrophic cardiomyopathy:distribution of disease genes,spectrum of mutations,and implications for a molecular diagnosis strategy[J].Circulation,2003,107(17):2227-2232.
[2] Authors/Task Force members,Elliott P M,Anastasakis A,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy:the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC)[J]. Eur Heart J,2014,35(39):2733-2779.
[3] Jiang H,Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China[J]. Heart,2009,95(21):1727-1731.
[4]黄艳梅,别彩群,董丽妍,等. 21例梗阻性肥厚型心肌病化学消融治疗近期疗效观察[J].海南医学,2012,23(9):4-6.
[5] Ooman A,Ranachandran P. Percutaneous transluminal septal myocardial ablation in drug resistant hypertrophic obstructive cardiomyopathy:18 month follow up results[J]. J Invasive Cardiol,2001,13(7):526-530.
[6]来鸣,何文姬,王含芝,等. 16例肥厚型心肌病化学消融术后心肌酶谱分析与护理[J].中华护理杂志,2007,42(10):911-913.
[7]康立惠,孙涛,路慧,等.肥厚性梗阻型心肌病病人行室间隔化学消融术的临床护理[J].护理研究,2018(17):2812-2815.
[8]王晓红,刘华芬,刘秀娟,等.化学消融治疗肥厚性梗阻型心肌病术中监测及护理配合[J].护理研究,2007,21(28):2600-2601.
[9]吕园园,杨志敏,刘蓉.肥厚梗阻型心肌病化学消融术后合并晚发Ⅲ度房室传导阻滞患者的护理[J].中华现代护理杂志,2013,19(4):395-397.
[10]方建梅,王海双,叶虹,等.对经皮腔内室间隔心肌化学消融术病人并发症的护理干预[J].护理研究,2008,22(3):248-249.
[11]李敏,王齐兵,朱文青,等. 234例肥厚型心肌病临床总结[J].临床心血管病杂志,2008,24(6):418-420.
[12]王帆,郭秀琴.经皮室间隔心肌化学消融术治疗肥厚梗阻型心肌病术后并发症的观察及护理[J].中华护理杂志,2014,49(4):503-505.
[13]刘艳萍,杨红蕾,范晓燕,等.经皮室间隔隧道心肌化学消融术治疗中青年肥厚梗阻型心肌病12例围术期护理[J].齐鲁护理杂志,2015,21(10):45-46.
[14]黄丽.化学消融治疗肥厚型梗阻心肌病观察护理[J].世界最新医学信息文摘:电子版,2014,14(22):211-211.
[15]俞旺娣,袁莉华,欧阳利群. 12例肥厚梗阻型心肌病化学消融术后并发心律失常的观察护理[J].实用临床医学(江西),2013,14(3):109-111.
[16]吴小红.肥厚型梗阻性心肌病化学消融术的护理[J].现代医药卫生,2012,28(22):3468-3469.
[2] Authors/Task Force members,Elliott P M,Anastasakis A,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy:the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC)[J]. Eur Heart J,2014,35(39):2733-2779.
[3] Jiang H,Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China[J]. Heart,2009,95(21):1727-1731.
[4]黄艳梅,别彩群,董丽妍,等. 21例梗阻性肥厚型心肌病化学消融治疗近期疗效观察[J].海南医学,2012,23(9):4-6.
[5] Ooman A,Ranachandran P. Percutaneous transluminal septal myocardial ablation in drug resistant hypertrophic obstructive cardiomyopathy:18 month follow up results[J]. J Invasive Cardiol,2001,13(7):526-530.
[6]来鸣,何文姬,王含芝,等. 16例肥厚型心肌病化学消融术后心肌酶谱分析与护理[J].中华护理杂志,2007,42(10):911-913.
[7]康立惠,孙涛,路慧,等.肥厚性梗阻型心肌病病人行室间隔化学消融术的临床护理[J].护理研究,2018(17):2812-2815.
[8]王晓红,刘华芬,刘秀娟,等.化学消融治疗肥厚性梗阻型心肌病术中监测及护理配合[J].护理研究,2007,21(28):2600-2601.
[9]吕园园,杨志敏,刘蓉.肥厚梗阻型心肌病化学消融术后合并晚发Ⅲ度房室传导阻滞患者的护理[J].中华现代护理杂志,2013,19(4):395-397.
[10]方建梅,王海双,叶虹,等.对经皮腔内室间隔心肌化学消融术病人并发症的护理干预[J].护理研究,2008,22(3):248-249.
[11]李敏,王齐兵,朱文青,等. 234例肥厚型心肌病临床总结[J].临床心血管病杂志,2008,24(6):418-420.
[12]王帆,郭秀琴.经皮室间隔心肌化学消融术治疗肥厚梗阻型心肌病术后并发症的观察及护理[J].中华护理杂志,2014,49(4):503-505.
[13]刘艳萍,杨红蕾,范晓燕,等.经皮室间隔隧道心肌化学消融术治疗中青年肥厚梗阻型心肌病12例围术期护理[J].齐鲁护理杂志,2015,21(10):45-46.
[14]黄丽.化学消融治疗肥厚型梗阻心肌病观察护理[J].世界最新医学信息文摘:电子版,2014,14(22):211-211.
[15]俞旺娣,袁莉华,欧阳利群. 12例肥厚梗阻型心肌病化学消融术后并发心律失常的观察护理[J].实用临床医学(江西),2013,14(3):109-111.
[16]吴小红.肥厚型梗阻性心肌病化学消融术的护理[J].现代医药卫生,2012,28(22):3468-3469.